Once Nightly Treatment for Narcolepsy and Other Sleep Disorders with Dr. Jordan Dubow Avadel Pharmaceuticals TRANSCRIPT

 
シェア
 

Manage episode 267114553 series 99915
著作 Karen Jagoda の情報はPlayer FM及びコミュニティによって発見されました。著作権は出版社によって所持されます。そして、番組のオーディオは、その出版社のサーバから直接にストリーミングされます。Player FMで購読ボタンをタップし、更新できて、または他のポッドキャストアプリにフィードのURLを貼り付けます。

Dr. Jordan Dubow, Chief Medical Officer, Avadel Pharmaceuticals, intent on improving drug delivery technology, is focusing on narcolepsy, a disease that causes severe excessive sleepiness and in many cases cataplexy. While there seems to be a genetic predisposition for narcolepsy, like many neurological diseases, this rare disease is difficult to diagnose with medicines that treat daytime sleepiness and cataplexy episodes presenting significant limitations. Avadel's once-nightly FT218 is an extended release long acting version of sodium oxybate that treats both features of the disease and allows patients to get a full night sleep without need for middle of the night dosing.

@AvadelPharma #narcolepsy #SleepDisorder #EDS #cataplexy

Avadel.com

Listen to the podcast here.

457 つのエピソード